Literature DB >> 26076833

Single-Nucleotide Polymorphism of the FKBP5 Gene and Childhood Maltreatment as Predictors of Structural Changes in Brain Areas Involved in Emotional Processing in Depression.

Leonardo Tozzi1, Angela Carballedo1,2, Friedrich Wetterling1, Hazel McCarthy1, Veronica O'Keane3, Michael Gill4, Derrek Morris4, Ciara Fahey4, James Meaney2, Thomas Frodl1,2,5,6.   

Abstract

The gene expressing the FK506 binding protein 51 (FKBP5) is involved in the regulation of glucocorticoid receptor sensitivity. The rs1360780 SNP in this gene (T allele vs C homozygous) has been found to be associated with major depressive disorder (MDD). The aim of our study was to investigate whether this polymorphism might be associated with altered brain structure and function in a cohort of 40 patients with MDD and 43 healthy controls. A functional magnetic resonance imaging (fMRI) emotional attention task was employed. Diffusion tensor imaging (DTI) was also conducted, extracting mean diffusivity (MD) and fractional anisotropy (FA) from brain areas that showed functional differences between patients expressing the two alleles of the rs1360780 SNP. Finally, the effect of the interaction of childhood adversity as measured by the Childhood trauma Questionnaire (CTQ) and rs1360780 allele status was analyzed in relation to DTI measures using a general linear model. All results presented are family-wise error (FWE) corrected. Functional interactions were found between genotype and diagnosis (p<0.01). Patients carrying the high-risk allele, compared with patients not carrying it, showed reduced activity in the rolandic operculum, Heschl gyrus, insula, parahippocampal gyrus, posterior cingulate cortex, inferior frontal gyrus (p<0.05 for all measures); and increased MD and reduced FA measures in many of these regions (p<0.05). An interaction between CTQ scores and allele status was associated with DTI changes in the insula, rolandic operculum, and inferior frontal gyrus. Here, the presence of both the high-risk allele and higher CTQ scores was associated with higher MD and lower FA values (p<0.05). In conclusion, MDD patients expressing the T allele of rs1360780, compared with C homozygous patients, exhibit functional and structural differences in areas involved in emotional perception and inhibition. The interaction between the T allele and childhood maltreatment explained our structural findings in these regions, suggesting that their altered maturation and function might be influenced by early chronic stress in the presence of this genetic trait.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26076833      PMCID: PMC5130124          DOI: 10.1038/npp.2015.170

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  45 in total

1.  Deactivation of the limbic system during acute psychosocial stress: evidence from positron emission tomography and functional magnetic resonance imaging studies.

Authors:  Jens C Pruessner; Katarina Dedovic; Najmeh Khalili-Mahani; Veronika Engert; Marita Pruessner; Claudia Buss; Robert Renwick; Alain Dagher; Michael J Meaney; Sonia Lupien
Journal:  Biol Psychiatry       Date:  2007-08-08       Impact factor: 13.382

2.  Neural correlates of treatment outcome in major depression.

Authors:  Danuta Lisiecka; Eva Meisenzahl; Johanna Scheuerecker; Veronica Schoepf; Peter Whitty; Aisling Chaney; Hans-Juergen Moeller; Martin Wiesmann; Thomas Frodl
Journal:  Int J Neuropsychopharmacol       Date:  2010-12-23       Impact factor: 5.176

3.  Cognitive control and brain resources in major depression: an fMRI study using the n-back task.

Authors:  Philippe-Olivier Harvey; Philippe Fossati; Jean-Baptiste Pochon; Richard Levy; Guillaume Lebastard; Stéphane Lehéricy; Jean-François Allilaire; Bruno Dubois
Journal:  Neuroimage       Date:  2005-04-08       Impact factor: 6.556

4.  5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression.

Authors:  Udo Dannlowski; Patricia Ohrmann; Jochen Bauer; Jürgen Deckert; Christa Hohoff; Harald Kugel; Volker Arolt; Walter Heindel; Anette Kersting; Bernhard T Baune; Thomas Suslow
Journal:  Neuropsychopharmacology       Date:  2007-04-04       Impact factor: 7.853

5.  Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort.

Authors:  Catharina Lavebratt; Elin Aberg; Louise K Sjöholm; Yvonne Forsell
Journal:  J Affect Disord       Date:  2010-03-12       Impact factor: 4.839

6.  The insular cortex and the neuroanatomy of major depression.

Authors:  Reiner Sprengelmeyer; J Douglas Steele; Benson Mwangi; Poornima Kumar; David Christmas; Maarten Milders; Keith Matthews
Journal:  J Affect Disord       Date:  2011-04-29       Impact factor: 4.839

7.  Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features.

Authors:  Greg J Siegle; Wesley Thompson; Cameron S Carter; Stuart R Steinhauer; Michael E Thase
Journal:  Biol Psychiatry       Date:  2006-10-06       Impact factor: 13.382

8.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

9.  Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.

Authors:  Sonja Horstmann; Susanne Lucae; Andreas Menke; Johannes M Hennings; Marcus Ising; Darina Roeske; Bertram Müller-Myhsok; Florian Holsboer; Elisabeth B Binder
Journal:  Neuropsychopharmacology       Date:  2009-11-18       Impact factor: 7.853

10.  FKBP5 genotype and structural integrity of the posterior cingulum.

Authors:  Negar Fani; Tricia Z King; Emily Reiser; Elisabeth B Binder; Tanja Jovanovic; Bekh Bradley; Kerry J Ressler
Journal:  Neuropsychopharmacology       Date:  2013-11-20       Impact factor: 7.853

View more
  20 in total

1.  Epigenetic Changes of FKBP5 as a Link Connecting Genetic and Environmental Risk Factors with Structural and Functional Brain Changes in Major Depression.

Authors:  Leonardo Tozzi; Chloe Farrell; Linda Booij; Kelly Doolin; Zsofia Nemoda; Moshe Szyf; Florence B Pomares; Julian Chiarella; Veronica O'Keane; Thomas Frodl
Journal:  Neuropsychopharmacology       Date:  2017-11-28       Impact factor: 7.853

Review 2.  Neuroimaging genomic studies in major depressive disorder: A systematic review.

Authors:  Hui-Feng Zhang; David Mellor; Dai-Hui Peng
Journal:  CNS Neurosci Ther       Date:  2018-02-23       Impact factor: 5.243

3.  Childhood Adversities and Depression in Adulthood: Current Findings and Future Directions.

Authors:  Richard T Liu
Journal:  Clin Psychol (New York)       Date:  2017-03-23

4.  Local gyrification index in patients with major depressive disorder and its association with tryptophan hydroxylase-2 (TPH2) polymorphism.

Authors:  Kyu-Man Han; Eunsoo Won; June Kang; Aram Kim; Ho-Kyoung Yoon; Hun Soo Chang; Kyu Ri Son; Min-Soo Lee; Woo-Suk Tae; Byung-Joo Ham
Journal:  Hum Brain Mapp       Date:  2016-11-03       Impact factor: 5.038

5.  Reduced DNA methylation of FKBP5 in Cushing's syndrome.

Authors:  Eugenia Resmini; Alicia Santos; Anna Aulinas; Susan M Webb; Yolanda Vives-Gilabert; Olivia Cox; Gary Wand; Richard S Lee
Journal:  Endocrine       Date:  2016-09-23       Impact factor: 3.633

Review 6.  Interaction between early-life stress and FKBP5 gene variants in major depressive disorder and post-traumatic stress disorder: A systematic review and meta-analysis.

Authors:  Qingzhong Wang; Richard C Shelton; Yogesh Dwivedi
Journal:  J Affect Disord       Date:  2017-08-24       Impact factor: 4.839

7.  Childhood Maltreatment and Headache Disorders.

Authors:  Gretchen E Tietjen
Journal:  Curr Pain Headache Rep       Date:  2016-04

8.  Reduced fractional anisotropy in depressed patients due to childhood maltreatment rather than diagnosis.

Authors:  Susanne Meinert; Jonathan Repple; Igor Nenadic; Axel Krug; Andreas Jansen; Dominik Grotegerd; Katharina Förster; Verena Enneking; Katharina Dohm; Simon Schmitt; Frederike Stein; Katharina Brosch; Tina Meller; Ronny Redlich; Joscha Böhnlein; Lisa Sindermann; Janik Goltermann; Elisabeth J Leehr; Nils Opel; Leni Aldermann; Andreas Reuter; Ricarda I Schubotz; Tim Hahn; Tilo Kircher; Udo Dannlowski
Journal:  Neuropsychopharmacology       Date:  2019-08-05       Impact factor: 7.853

9.  FKBP5 Moderates the Association between Antenatal Maternal Depressive Symptoms and Neonatal Brain Morphology.

Authors:  Changqing Wang; Mojun Shen; Bryan Guillaume; Yap-Seng Chong; Helen Chen; Marielle V Fortier; Michael J Meaney; Anqi Qiu
Journal:  Neuropsychopharmacology       Date:  2017-10-03       Impact factor: 7.853

Review 10.  Hsp90 and FKBP51: complex regulators of psychiatric diseases.

Authors:  Marangelie Criado-Marrero; Theo Rein; Elisabeth B Binder; James T Porter; John Koren; Laura J Blair
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.